Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study
Open Access
- 6 January 2015
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 112 (4) , 660-666
Abstract
Incomplete surgical staging is a negative prognostic factor for patients with borderline ovarian tumours (BOT). However, little is known about the prognostic impact of each individual staging procedure. Clinical parameters of 950 patients with BOT (confirmed by central reference pathology) treated between 1998 and 2008 at 24 German AGO centres were analysed. In 559 patients with serous BOT and adequate ovarian surgery, further recommended staging procedures (omentectomy, peritoneal biopsies, cytology) were evaluated applying Cox regression models with respect to progression-free survival (PFS). For patients with one missing staging procedure, the hazard ratio (HR) for recurrence was 1.25 (95%-CI 0.66–2.39; P=0.497). This risk increased with each additional procedure skipped reaching statistical significance in case of two (HR 1.95; 95%-CI 1.06–3.58; P=0.031) and three missing steps (HR 2.37; 95%-CI 1.22–4.64; P=0.011). The most crucial procedure was omentectomy which retained a statistically significant impact on PFS in multiple analysis (HR 1.91; 95%-CI 1.15–3.19; P=0.013) adjusting for previously established prognostic factors as FIGO stage, tumour residuals, and fertility preservation. Individual surgical staging procedures contribute to the prognosis for patients with serous BOT. In this analysis, recurrence risk increased with each skipped surgical step. This should be considered when re-staging procedures following incomplete primary surgery are discussed.Keywords
This publication has 27 references indexed in Scilit:
- Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT studyAnnals of Oncology, 2014
- S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian TumoursGeburtshilfe und Frauenheilkunde, 2013
- Surgical management and perioperative morbidity of patients with primary borderline ovarian tumor (BOT)Journal of Ovarian Research, 2013
- Laparoscopic restaging of borderline ovarian tumours (BLOT): a retrospective study of 142 casesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumorWorld Journal of Surgical Oncology, 2013
- Borderline Tumors of the Ovary: Clinical Course and Prognostic FactorsOnkologie, 2012
- Accuracy of frozen section diagnosis of borderline ovarian tumorsGynecologic Oncology, 2011
- Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancerEuropean Journal of Surgical Oncology, 2010
- Restaging surgery for women with borderline ovarian tumorsCancer, 2004
- Surgical staging in patients with ovarian tumors of low malignant potentialObstetrics & Gynecology, 2002